250 related articles for article (PubMed ID: 36421708)
1. Essential Components of Synthetic Infectious Prion Formation De Novo.
Jack K; Jackson GS; Bieschke J
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421708
[TBL] [Abstract][Full Text] [Related]
2. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
3. Prion protein amino acid sequence influences formation of authentic synthetic PrP
Block AJ; York TC; Benedict R; Ma J; Bartz JC
Sci Rep; 2023 Jan; 13(1):441. PubMed ID: 36624174
[TBL] [Abstract][Full Text] [Related]
4. De novo generation of infectious prions in vitro produces a new disease phenotype.
Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
[TBL] [Abstract][Full Text] [Related]
5. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
6. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
Igel A; Fornara B; Rezaei H; Béringue V
Cell Tissue Res; 2023 Apr; 392(1):149-166. PubMed ID: 36399162
[TBL] [Abstract][Full Text] [Related]
7. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
8. A systematic investigation of production of synthetic prions from recombinant prion protein.
Schmidt C; Fizet J; Properzi F; Batchelor M; Sandberg MK; Edgeworth JA; Afran L; Ho S; Badhan A; Klier S; Linehan JM; Brandner S; Hosszu LL; Tattum MH; Jat P; Clarke AR; Klöhn PC; Wadsworth JD; Jackson GS; Collinge J
Open Biol; 2015 Dec; 5(12):150165. PubMed ID: 26631378
[TBL] [Abstract][Full Text] [Related]
9. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
10. A new model for sensitive detection of zoonotic prions by PrP transgenic Drosophila.
Thackray AM; Andréoletti O; Spiropoulos J; Bujdoso R
J Biol Chem; 2021 Aug; 297(2):100878. PubMed ID: 34270959
[TBL] [Abstract][Full Text] [Related]
11.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
12. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Prion Selection and Adaptation.
Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
[TBL] [Abstract][Full Text] [Related]
14. The first non-prion pathogen identified: neurotropic influenza virus.
Sakaguchi S; Hara H
Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
[TBL] [Abstract][Full Text] [Related]
15. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
[TBL] [Abstract][Full Text] [Related]
16. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
17. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
Eraña H; Charco JM; Di Bari MA; Díaz-Domínguez CM; López-Moreno R; Vidal E; González-Miranda E; Pérez-Castro MA; García-Martínez S; Bravo S; Fernández-Borges N; Geijo M; D'Agostino C; Garrido J; Bian J; König A; Uluca-Yazgi B; Sabate R; Khaychuk V; Vanni I; Telling GC; Heise H; Nonno R; Requena JR; Castilla J
PLoS Pathog; 2019 Oct; 15(10):e1008117. PubMed ID: 31644574
[TBL] [Abstract][Full Text] [Related]
18. Converting the prion protein: what makes the protein infectious.
Baskakov IV; Breydo L
Biochim Biophys Acta; 2007 Jun; 1772(6):692-703. PubMed ID: 16935473
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.
Terry C; Wenborn A; Gros N; Sells J; Joiner S; Hosszu LL; Tattum MH; Panico S; Clare DK; Collinge J; Saibil HR; Wadsworth JD
Open Biol; 2016 May; 6(5):. PubMed ID: 27249641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
